How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PT

OOTC:PTEO
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PT

Proteo IncOOTC PTEO Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is PTEO undervalued compared to its fair value?

The fair value of PTEO stock is hidden USD. Relative to the market price of 0 USD Proteo Inc is hidden.

Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company is headquartered in Irvine, California. The firm intends to develo...[More about valuation]

Proteo Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.003 $B

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-16.179

FINANCIALS

Proteo financial for reporting period

Income Statement

0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0 B 100%
-0.0001 B -12454%
0 B -9404%

Balance Sheet

0.0004 B
-0.0005 B

Financial Position Analysis

Assets

0.0004 B
Current Assets
0.0004 B
Total non-current assets
0 B

Total current liabilities
0.0001 B
Total non-current liabilities
0.0008 B

Cash Flow Statement

0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Proteo fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-694 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-78 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is PTEO attractive for investment based on fundamental analysis?

PTEO stock rating is hidden. Proteo is a hidden by Eyestock methodology.

Get PTEO Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-48 181

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

2.777

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

PTEO analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for PTEO to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Proteo Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Proteo Inc dividends

PTEO dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About PTEO stock

About the company Proteo Inc

Market cap $B

0.003

Dividend yield

Shares outstanding

Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company is headquartered in Irvine, California. The firm intends to develop, promote and market pharmaceuticals and other biotech products. The company is focusing its research on the development of drugs based on the human protein Elafin, which is used for the treatment of post-surgery damage to tissue, complications resulting from organ transplantation, pulmonary hypertension, serious injuries. The firm has obtained Orphan drug designations within the European Union for the use of Elafin for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as well as for the treatment of esophageal cancer. Within the United States, it has obtained Orphan drug designations for the use of Elafin for the treatment of pulmonary arterial hypertension as well as for the prevention of inflammatory complications of transthoracic esophagectomy.

PTEO profile

  • Ticker

    PTEO

  • Country

    USA

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    17 October 2001

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

  • City

    Irvine

  • Address

    2102 Business Center Drive

  • Cusip

    74369R407